Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

ADAPY holding history

Adaptimmune Therapeutics PLC in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADAPY overviewAll 13F holders of ADAPYFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ADAPY by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−4,054,089−100.0%Sold outHolders
Q3 20254,054,089$527.0K<0.1%+2,171,229+115.3%AddedHolders
Q2 20251,882,860$451.3K<0.1%+69,000+3.8%AddedHolders
Q1 20251,813,860$357.3K<0.1%−712,664−28.2%ReducedHolders
Q4 20242,526,524$1.36M<0.1%+869,949+52.5%AddedHolders
Q3 20241,656,575$1.57M<0.1%−129,766−7.3%ReducedHolders
Q2 20241,786,341$1.74M<0.1%+394,566+28.3%AddedHolders
Q1 20241,391,775$2.20M<0.1%+21,536+1.6%AddedHolders
Q4 20231,370,239$1.09M<0.1%+342,379+33.3%AddedHolders
Q3 20231,027,860$802.0K<0.1%−478,515−31.8%ReducedHolders
Q2 20231,506,375$1.39M<0.1%+1,323,675+724.5%AddedHolders
Q1 2023182,700$199.0K<0.1%−378,273−67.4%ReducedHolders
Q4 2022560,973$819.0K<0.1%−5,259−0.9%ReducedHolders
Q3 2022566,232$609.0K<0.1%+56,232+11.0%AddedHolders
Q2 2022510,000$867.0K<0.1%−449,703−46.9%ReducedHolders
Q1 2022959,703$1.98M<0.1%+532,016+124.4%AddedHolders
Q4 2021427,687$1.60M<0.1%+427,687NewHolders
Q3 20210$00.0%−303,495−100.0%Sold outHolders
Q2 2021303,495$1.29M<0.1%+202,495+200.5%AddedHolders
Q1 2021101,000$536.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.